StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

Equities researchers at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a report issued on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Stock Performance

Shares of CUTR opened at $0.40 on Monday. The business’s 50 day moving average price is $0.39 and its two-hundred day moving average price is $0.74. Cutera has a 52-week low of $0.28 and a 52-week high of $3.73. The firm has a market cap of $8.14 million, a PE ratio of -0.06 and a beta of 1.26.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Bank of Montreal Can raised its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 14.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 282,704 shares of the medical device company’s stock after purchasing an additional 35,248 shares during the period. Bank of Montreal Can owned approximately 1.41% of Cutera worth $455,000 at the end of the most recent reporting period. 90.70% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.